Cargando…

Gut microbiota-dependent CCR9(+)CD4(+) T cells are altered in secondary progressive multiple sclerosis

The mechanism underlying the progression of relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis (SPMS), characterized by accumulating fixed disability, is yet to be fully understood. Although alterations in the gut microbiota have recently been highlighted in multiple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadowaki, Atsushi, Saga, Ryoko, Lin, Youwei, Sato, Wakiro, Yamamura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439331/ https://www.ncbi.nlm.nih.gov/pubmed/30770703 http://dx.doi.org/10.1093/brain/awz012

Ejemplares similares

First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis
por: Sato, Wakiro, et al.
Publicado: (2023)

Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3
por: Kadowaki, Atsushi, et al.
Publicado: (2016)

Involvement of cytotoxic Eomes-expressing CD4(+) T cells in secondary progressive multiple sclerosis
por: Raveney, Ben J. E., et al.
Publicado: (2021)

Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis
por: Takewaki, Daiki, et al.
Publicado: (2020)

Th1 ‐ CD11c (+) B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2021)

Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis
por: Akaike, Shun, et al.
Publicado: (2023)

Disrupted balance of T cells under natalizumab treatment in multiple sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2016)

Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
por: Takahashi, Junichiro, et al.
Publicado: (2023)

Application of immunotherapy for neurological manifestations in hypermobile Ehlers–Danlos syndrome
por: Araki, Manabu, et al.
Publicado: (2018)

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
por: Miyake, Sachiko, et al.
Publicado: (2015)

Resident Memory-like CD8(+) T Cells Are Involved in Chronic Inflammatory and Neurodegenerative Diseases in the CNS
por: Kimura, Kimitoshi, et al.
Publicado: (2023)

Chemokine receptor CCR9 suppresses the differentiation of CD4(+)CD8αα(+) intraepithelial T cells in the gut
por: Li, Can, et al.
Publicado: (2022)

A multiple sclerosis patient-oriented multiomics analysis tells us where to go next: Commentary for: “Alterations of host-gut microbiome interactions in multiple sclerosis”
por: Yamamura, Takashi, et al.
Publicado: (2022)

Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2018)

Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis
por: Takewaki, Daiki, et al.
Publicado: (2018)

57 Increased Frequency of CD4+ CCR4+ CCR9+ Cells in Patients With Allergic Conjunctivitis
por: Alonso-Sánchez, Miguel E., et al.
Publicado: (2012)

Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder
por: Matsuoka, Takako, et al.
Publicado: (2023)

Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
por: Khadka, Sundar, et al.
Publicado: (2021)

Possible effects of electroconvulsive therapy on refractory psychosis in primary progressive multiple sclerosis: A case report
por: Narita, Zui, et al.
Publicado: (2018)

Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Corrigendum: Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
por: Khadka, Sundar, et al.
Publicado: (2022)

Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis
por: Saresella, Marina, et al.
Publicado: (2020)

The Heteromeric Complex Formed by Dopamine Receptor D(5) and CCR9 Leads the Gut Homing of CD4(+) T Cells Upon Inflammation
por: Osorio-Barrios, Francisco, et al.
Publicado: (2021)

Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP
por: Yamano, Yoshihisa, et al.
Publicado: (2015)

Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
por: Kamo, Takehiro, et al.
Publicado: (2017)

Interaction between NANOS2 and the CCR4-NOT Deadenylation Complex Is Essential for Male Germ Cell Development in Mouse
por: Suzuki, Atsushi, et al.
Publicado: (2012)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
por: Raveney, Ben J. E., et al.
Publicado: (2015)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020)

Altered gut microbiota in Rett syndrome
por: Strati, Francesco, et al.
Publicado: (2016)

Altered Gut Microbiota in Myasthenia Gravis
por: Qiu, Dongxu, et al.
Publicado: (2018)

Altered Gut Microbiota in Children With Hyperuricemia
por: Yuan, Xin, et al.
Publicado: (2022)

Alteration of the Gut Microbiota in Missed Abortion
por: Chen, Yi, et al.
Publicado: (2023)

Hybridization altered the gut microbiota of pigs
por: Wei, Limin, et al.
Publicado: (2023)

An Imbalance between Frequency of CD4+CD25+FOXP3+ Regulatory T Cells and CCR4+ and CCR9+ Circulating Helper T Cells Is Associated with Active Perennial Allergic Conjunctivitis
por: Galicia-Carreón, J., et al.
Publicado: (2013)

The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
por: Schepici, Giovanni, et al.
Publicado: (2019)

The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
por: Tremlett, Helen, et al.
Publicado: (2021)

The gut microbiota in multiple sclerosis varies with disease activity
por: Thirion, Florence, et al.
Publicado: (2023)

Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives
por: Altieri, Clelia, et al.
Publicado: (2023)

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
por: Bahr, S M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9l43hprsvsvgvp2kp17vkvqtgf